Literature DB >> 32829303

Brolucizumab: the road ahead.

Ashish Sharma1, Nilesh Kumar2, Francesco Bandello3, Baruch D Kuppermann4, Anat Loewenstein5, Carl D Regillo6.   

Abstract

Entities:  

Keywords:  Drugs; Immunology; Retina

Mesh：

Substances：

Year:  2020        PMID： 32829303     DOI： 10.1136/bjophthalmol-2020-317528

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  1 in total

1.  Three-Month Results of Brolucizumab Intravitreal Therapy in Patients with Wet Age-Related Macular Degeneration.

Authors:  Katarzyna Michalska-Małecka; Dorota Śpiewak; Dorota Luksa
Journal:  Int J Environ Res Public Health       Date:  2021-08-10       Impact factor: 3.390
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.